Quinacrine treatment trial for sporadic Creutzfeldt-Jakob disease

OBJECTIVE: To determine whether oral quinacrine increases survival in sporadic Creutzfeldt-Jakob disease (sCJD). METHODS: This NIH/National Institute on Aging–funded, double-blinded, placebo-controlled, stratified randomization treatment trial was conducted at the University of California, San Franc...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Geschwind, Michael D., Kuo, Amy L., Wong, Katherine S., Haman, Aissa, Devereux, Gillian, Raudabaugh, Benjamin J., Johnson, David Y., Torres-Chae, Charles C., Finley, Ron, Garcia, Paul, Thai, Julie N., Cheng, Hugo Q., Neuhaus, John M., Forner, Sven A., Duncan, Jacque L., Possin, Katherine L., DeArmond, Stephen J., Prusiner, Stanley B., Miller, Bruce L.
Formato: Artigo
Idioma:Inglês
Publicado em: Lippincott Williams & Wilkins 2013
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4211922/
https://ncbi.nlm.nih.gov/pubmed/24122181
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/WNL.0b013e3182a9f3b4
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados